Clinical Trial Update: Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Brentuximab Vedotin followed by ABVD in patients with previously untreated Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Bleomycin (bleomycin)
• Brentuximab vedotin (Brentuximab vedotin)
• Dacarbazine (dacarbazine)
• Doxorubicin (doxorubicin)
• Vinblastine (vinblastine)

Snippet

Sponsor: University of Modena and Reggio Emilia | Conditions: Hodgkin Lymphoma | Phase 2 | Status: UNKNOWN